Navigation Links
Marken Opens Two Pharmaceutical Depots In New York & Germany
Date:8/30/2012

RESEARCH TRIANGLE PARK, N.C., Aug. 30, 2012 /PRNewswire/ -- Marken announced today the completion of the first phase of its plan to create a global pharmaceutical depot network that will allow it to satisfy its clients' needs for global distribution. Two new depots have been completed:  one in Frankfurt, Germany and one in Farmingdale, New York. The launch of these two central depots, when added to the existing operational depots in Singapore, Mexico and Argentina and further supplemented by its own 3rd party depot network, now completes Phase I of the global Marken depot network plan. This network has been built based on an extensive analysis of client needs as well as geographical needs, allowing large Phase III clinical trials to be conducted in a cost efficient and optimized manner.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

"Today marks an important milestone for Marken.  Having these two new central depots allows us to serve our clients with global distribution services and, more importantly, to serve our clients who seek comprehensive and efficient global distribution.  Phase One is complete.  We are now pushing forward with Phase Two, which will include more depots in key countries around the world such as China, Brazil and Russia," said Gerit Offenhauser, Senior Vice President, Clinical Trials Distribution for Marken.

Marken's depots provide secure temperature controlled storage and distribution for drugs, medical devices and diagnostic equipment.  They are located near existing branch operations in order to take advantage of well established customer service, operations import /export and administrative support. Each of Marken's depots are connected through the Solo platform, a state-of-the-art, 21 CFR part 11 validated, cloud based inventory management system which can interface with IRT for improved inventory reconciliation.  This interface allows our client to track dosages at the patient level.

Wes Wheeler, Chief Executive Officer of Marken, said, "We are proud to expand our pharmaceutical service depot network to Frankfurt and New York. Having a presence in these cities ensures that Marken continues to serve our clients with full service, global clinical supply chain solutions.  Marken will continue to invest in facilities and technologies which will provide the highest quality courier and logistics services."

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment in naive geographies.

www.marken.com


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Marken Launches Exclusive Shipping System for Specimen Logistics
2. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
3. CoreLab Partners Opens Office in Tokyo, Japan
4. Alchem International Opens Sales and Marketing Office in the U.S.
5. Stevenage Bioscience Catalyst Opens With Exciting Year Ahead
6. PRA Opens Office in Singapore
7. Discovery opens door to low-cost negative refraction, new products and industries
8. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
9. Data mining opens the door to predictive neuroscience
10. Scotland opens stem cell research center and bio-medical incubator
11. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... , ... Dr. Asher Kimchi, Founder and Chairman of the International Academy ... the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. In addition ... Fellowship Awards. , Dr. Asher Kimchi, together with Co-Chairmen Dr. John A. Elefteriades and ...
(Date:7/20/2017)... , ... July 20, 2017 , ... VIC Technology ... joining the company’s board of directors. This addition continues to strengthen and diversify ... Calvin Goforth, CEO and Chairman. “He is a highly accomplished business executive with a ...
(Date:7/20/2017)... 20, 2017   KCNQ2 Cure Alliance  and ... company, today announced that they have completed the ... mutation implicated in KCNQ2 epileptic encephalopathy. They also ... second case involving an additional KCNQ2 genetic mutation. ... and Pairnomix entered into a collaboration to further ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
Breaking Biology Technology:
(Date:6/30/2017)... , June 30, 2017 Today, ... developer and supplier of face and eye tracking ... Featured Product provider program. "Artificial ... innovative way to monitor a driver,s attentiveness levels ... from being able to detect fatigue and prevent ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
Breaking Biology News(10 mins):